Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Pure and Applied Chemistry

The Scientific Journal of IUPAC

Ed. by Burrows, Hugh / Weir, Ron / Stohner, Jürgen

12 Issues per year


IMPACT FACTOR 2016: 2.626
5-year IMPACT FACTOR: 3.210

CiteScore 2016: 2.45

SCImago Journal Rank (SJR) 2016: 0.972
Source Normalized Impact per Paper (SNIP) 2016: 1.049

Online
ISSN
1365-3075
See all formats and pricing
More options …
Volume 80, Issue 10 (Jan 2008)

Issues

Protocols on safety, efficacy, standardization, and documentation of herbal medicine (IUPAC Technical Report)

M. Mosihuzzaman
  • Corresponding author
  • H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan
/ M. Iqbal Choudhary
  • Corresponding author
  • H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan
Published Online: 2009-01-01 | DOI: https://doi.org/10.1351/pac200880102195

This Technical Report compiles and analyzes the current scientific knowledge on herbal medicine and highlights the practical ways for ensuring the safety of herbal preparations and evaluating their claimed efficacy. Emphasis has been given to the methods for standardization of herbal medicine and the ways and means for moving forward to achieve the difficult goal of preparing herbal medicines of consistent quality and effects. Pragmatic approaches have been recommended to overcome the difficulties in (i) protecting intellectual property rights (IPR); (ii) producing safe, potent, standardized, and affordable herbal medicine; and (iii) documenting the knowledge base on herbal medicine in an easily accessible format.

Keywords: documentation; efficacy; herbal medicine; intellectual property rights; IUPAC Organic and Biomolecular Chemistry Division; safety; standardization; task group

Project Year: 2005, Project Code: 2005-034-1-300

References

  • 1.

    British Medical Association. Complementary Medicine New Approaches to Good Practice, Oxford University Press, Oxford (1993).Google Scholar

  • 2.

    R. C. Kessler, R. B. Davis, D. A. Foster, M. I. Van Rompay, E. E. Walters, S. A. Wilkey, T. J. Kaptchuk, D. M. Eisenberg. Ann. Intern. Med. 135, 262 (2001).Google Scholar

  • 3.

    , A. H. MacLennan, D. H. Wilson, A. W. Taylor. Prev. Med. 35, 166 (2002).CrossrefGoogle Scholar

  • 4.

    , C. M. Cassidy. J. Altern. Complement. Med. 4, 17 (1998).CrossrefGoogle Scholar

  • 5.

    A. Bensoussan, S. P. Myers. Towards a Safer Choice: The Practice of Traditional Chinese Medicine in Australia, Faculty of Health, University of Western Sydney, Macarthur (1996).Google Scholar

  • 6.

    TDR 2005. Operational Guidance: Information Needed to Support Clinical Trials of Herbal Products, UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) (2005).Google Scholar

  • 7.

    , E. Ernst. Clin. Pharmacol. Ther. 70, 497 (2001).CrossrefGoogle Scholar

  • 8.

    , E. Ernst. J. Intern. Med. 252, 107 (2002).CrossrefGoogle Scholar

  • 9.

    , E. Ernst. Trends Pharmacol. Sci. 23, 136 (2002).CrossrefGoogle Scholar

  • 10.

    P. A. G. M. De Smet, R. F. Chandler, P. P. H. But, K. Keller (Eds.). Adverse Effects of Herbal Drugs: Toxicological Outlook on the Quality Assurance of Herbal Medicines, pp. 1-72, Springer Verlag, Berlin (1992).Google Scholar

  • 11.

    "Quality of herbal remedies", in The Rules Governing Medicinal Products in the European Community, Office for Official Publications of the European Communities, Luxembourg, III, 31 (1989).Google Scholar

  • 12.

    , T. Y. K. Chan, J. C. N. Chan, B. Tomlinson, J. A. J. H. Critchley. Lancet 342, 1532 (1993).CrossrefGoogle Scholar

  • 13.

    S. Brown, R. Ede. Br. J. Hosp. Med. 53, 469 (1996).Google Scholar

  • 14.

    , H. H. Schaumburg, A. Berger. J. Am. Med. Assoc. 268, 3430 (1992).CrossrefGoogle Scholar

  • 15.

    , E. O. Espinoza, M.-J. Mann, B. Bleasdell. N. Engl. J. Med. 333, 803 (1995).CrossrefGoogle Scholar

  • 16.

    , R. J. Ko. N. Engl. J. Med. 339, 847 (1998).CrossrefGoogle Scholar

  • 17.

    G. M. Woolf, L. M. Petrovic, S. E. Rojter, S. Wainwright, F. G. Villamil, W. N. Katkov, P. Michieletti, I. R. Wanless, R. Stermitz, J. J. Beck, J. M. Vierling. Ann. Intern. Med. 121, 729 (1994).Google Scholar

  • 18.

    , J.-L. Vanherweghem, C. Tielemans, D. Abramowicz, M. Depierreux, R. Vanhaelen-Fastre, R. Vanhaelen, M. Vanhaelen, M. Drawta, C. Richard, D. Vendervelde, D. Verbeelen, M. Jadoul. Lancet 341, 387 (1993).CrossrefGoogle Scholar

  • 19.

    T. Y. K. Chan, J. A. J. H. Critchley. Hum. Exp. Toxicol. 15, 5 (1996).CrossrefGoogle Scholar

  • 20.

    T. J. Kaptchuk. Ann. Intern. Med. 122, 636 (1995).Google Scholar

  • 21.

    , G. J. Park, S. P. Mann, M. C. Ngu. J. Gastroenterol. Hepatol. 16, 115 (2001).CrossrefGoogle Scholar

  • 22.

    , P. P. But, D. J. Atherton, M. H. Rustin, J. Brostoff. Lancet 341, 637 (1993).CrossrefGoogle Scholar

  • 23.

    , M. Vanhaelen, R. Vanhaelen-Fastre, P. But, J.-L. Vanherweghem. Lancet 343, 174 (1994).CrossrefGoogle Scholar

  • 24.

    M. Depierreux, B. Van Damme, K. V. Houte, J.-L. Vanherweghem. Am. J. Kidney Dis. 24, 172 (1994).CrossrefGoogle Scholar

  • 25.

    , J.-P. Cosyns, M. Jadoul, J.-P. Squifflet, J.-F. De Plaen, D. Ferluga, C. V. Y. de Strihou. Kidney Int. 45, 1680 (1994).CrossrefGoogle Scholar

  • 26.

    P. A. G. M. De Smet, P. A. G. M. De Smet, K. Keller, R. Hansel, R. F. Chandler (Eds.). Adverse Effects of Herbal Drugs, Aristolochia Species, pp. 79-89, Springer Verlag, Berlin (1992).Google Scholar

  • 27.

    , L. J. Vanherwegham. J. Altern. Complement. Med. 4, 9 (1998).CrossrefGoogle Scholar

  • 28.

    , J.-P. Cosyns, M. Jadoul, J.-P. Squifflet, P.-J. Van Cangh, C. V. Y. de Strihou. Lancet 344, 188 (1994).CrossrefGoogle Scholar

  • 29.

    Therapeutic Goods Administration (TGA) (Australia). Chinese herbal medicines in Australia found to contain Aristolochia <http://www.tga.gov.au/> (2003).Google Scholar

  • 30.

    ICDRA. International Conference on Drug Regulatory Authorities, World Health Organization (1986).Google Scholar

  • 31.

    ICDRA. 6th International Conference on Drug Regulatory Authorities, World Health Organization (1991).Google Scholar

  • 32.

    ICDRA. 8th International Conference on Drug Regulatory Authorities, World Health Organization, Bahrain, 10-13 Nov. (1996).Google Scholar

  • 33.

    ICDRA. 9th International Conference on Drug Regulatory Authorities, World Health Organization, Berlin, 25-29 April (1999).Google Scholar

  • 34.

    G. Shia, B. Noller, G. Burford. "Safety issues and policies", in Traditional, Complementary and Alternative Medicine: Policy and Public Health Perspectives, G. Bodeker, G. Burford (Eds.), Chap. 4, pp. 83-98, Imperial College Press, London (2007).Google Scholar

  • 35.

    Therapeutic Goods Administration (TGA) (Australia). <http://www.tga.gov.au/cm/cm.htm> (2004).Google Scholar

  • 36.

    TDR. Operational Guidance: Information Needed to Support Clinical Trials of Herbal Products, UNICEF/UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR) (2005).Google Scholar

  • 37.

    P. F. Ricci. Environmental and Health Risk Assessment and Management: Principles and Practices, Springer, Dordrecht (2006).Google Scholar

  • 38.

    Standards Association of Australia. Risk Management AS/NZS, p. 4360, Strathfield, NSW (1999).Google Scholar

  • 39.

    M. R. Sim, J. J. McNeil. Med. J. Aust. 170, 372 (1999).Google Scholar

  • 40.

    EnHealth. Environmental Health Risk Assessment: Guidelines for Assessing Human Health Risks from Environmental Hazards, p. 227, Department of Health and Aged Care and enHealth Council, Canberra (2002).Google Scholar

  • 41.

    USEPA. Guidelines for Ecological Risk Assessment, p. 188, U.S. Environmental Protection Agency, Washington, DC (1998).Google Scholar

  • 42.

    Aristotle. Organon, in Masterpieces of World Philosophy, N. Magill (Ed.), p. 137, George Allen & Unwin, London (1963).Google Scholar

  • 43.

    C. H. Hennekens, J. E. Buring. "Design strategies in epidemiologic research", in Epidemiology in Medicine, S. L. Mayrent (Ed.), p. 16, Lippincott Williams & Wilkins, Philadelphia (1987).Google Scholar

  • 44.

    S. Plantadosis. In Clinical TrialsA Methodologic Perspective, Plantadosis (Ed.), p. 9, Wiley-Interscience, New York (2005).Google Scholar

  • 45.

    R. H. Fletcher, S. W. Fletcher. N. Eng. J. Med. 301, 180 (1979).Google Scholar

  • 46.

    S. Plantadosis. In Clinical TrialsA Methodologic Perspective, Plantadosis (Ed.), p. 82, Wiley-Interscience, New York (2005).Google Scholar

  • 47.

    , M. Pawa. In Complimentary Therapy and the Management of Diabetes and Vascular DiseaseA Matter of Balance, P. T. Dunning (Ed.), p. 17, John Wiley, Chichester (2006).CrossrefGoogle Scholar

  • 48.

    O. Akerele. Herbalgram 28, 13 (1993).Google Scholar

  • 49.

    J. Benedum. In Phytopharmaka IV. Forschung und Klinische Anwendung, D. Loew, N. E. Rietbrock (Eds.), p. 3, Darmstadt, Steinkopff (1998).Google Scholar

  • 50.

    B. Patwardhan, D. Warude, P. Pushpangadan, N. Bhatt. Evidence-Based Complem. Altern. Med. 2, 465 (2005).Google Scholar

  • 51.

    WHO. Traditional Medicine Strategy 2002-2005. <http://www.who.int/medicines/library/trm/trm_stat_eng.pdfS> (2002).Google Scholar

  • 52.

    J. Gruenwald. Herbalgram 34, 61 (1995).Google Scholar

  • 53.

    , L. Lee. J. Nurse-Midwifery 44, 253 (1999).CrossrefGoogle Scholar

  • 54.

    , J. S. Brown, S. A. Marcy. Res. Nurs. Health 14, 339 (1991).CrossrefGoogle Scholar

  • 55.

    , S. Bent, R. Ko. Am. J. Med. 116, 478 (2004).CrossrefGoogle Scholar

  • 56.

    , I. A. Khan. Life Sci. 78, 2033 (2006).CrossrefGoogle Scholar

  • 57.

    , J. L. Nortier, M.-C. M. Martinez, H. H. Schmeiser, V. M. Arlt, C. A. Bieler, M. Petein, F. Depierreux, L. De Pauw, D. Abramowicz, P. Vereerstraeten, J. L. Vanherweghem. N. Engl. J. Medicine 342, 1686 (2000).CrossrefGoogle Scholar

  • 58.

    , H. L. Koh, S. O. Woo. Drug Safety 23, 351 (2000).CrossrefGoogle Scholar

  • 59.

    , V. S. Srinivasan. Life Sci. 78, 2039 (2006).CrossrefGoogle Scholar

  • 60.

    , G. Ulrich-Merzenich, H. Zeitler, D. Jobst, D. Panek, H. Vetter, H. Wagner. Phytomedicine 14, 70 (2007).CrossrefGoogle Scholar

  • 61.

    EMEA. Position paper on the risks associated with the use of herbal products containing Aristolochia species. EMEA/HMPWP/23/00 (2000).Google Scholar

  • 62.

    , E. Ernst. Eur. J. Clin. Pharmacol. 56, 523 (2000).CrossrefGoogle Scholar

  • 63.

    , E. Ernst. J. Int. Med. 252, 107 (2002).CrossrefGoogle Scholar

  • 64.

    , L. C. Winslow, D. J. Kroll. Arch. Intern. Med. 158, 2192 (1998).CrossrefGoogle Scholar

  • 65.

    M. Rotblatt, I. Ziment. Evidence-Based Herbal Medicine, Hanley & Belfus, Philadelphia (2002).Google Scholar

  • 66.

    M. Blumenthal (Ed.). The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines, American Botanical Council, Austin, TX (1997).Google Scholar

  • 67.

    CDER/USFDA. Guidance for Industry, Botanical Drug Products, draft guidance, Center for Drug Evaluation and Research/U.S. Food and Drug Administration (2000).Google Scholar

  • 68.

    EMEA. Guideline on Specifications: Test Procedures and Acceptance Criteria for Herbal Drugs, Herbal Drug Preparations and Herbal Medicinal Products/Traditional Herbal Medicinal Products, European Medicines Agency, London, EMEA/CPMP/QWP/2820/00 Rev. 1 and (EMEA/CVMP/815/00), Rev. 1 (2006).Google Scholar

  • 69.

    The 2002 United States Pharmacopoeia and National Formulary, USP 25 NF 19/National Formulary 20, Rockville, MD, U.S. Pharmacopoeial Convention, Inc. (2002).Google Scholar

  • 70.

    Pharmacopoeia of the People's Republic of China, English ed., The Pharmacopoeia Commission of PRC, Beijing (2000).Google Scholar

  • 71.

    , C. W. Huie. Anal. Bioanal. Chem. 373, 23 (2002).CrossrefGoogle Scholar

  • 72.

    , V. Camel. Trends Anal. Chem. 19, 229 (2000).CrossrefGoogle Scholar

  • 73.

    , B. Kaufmann, S. Rudaz, S. Cherkaoui, J.-L. Veuthey, P. Christen. Phytochem. Anal. 18, 70 (2007).CrossrefGoogle Scholar

  • 74.

    , A. Brachet, S. Rudaz, L. Mateus, P. Christen, J.-L. Veuthey. J. Separation Sci. 24, 865 (2001).CrossrefGoogle Scholar

  • 75.

    , B. Kaufmann, P. Christen, J.-L. Veuthey. Chromatographia 54, 394 (2001).CrossrefGoogle Scholar

  • 76.

    , V. Fernandez-Perez, M. M. Jimenez-Carmona, M. D. L. De Castro. Analyst 125, 481 (2000).CrossrefGoogle Scholar

  • 77.

    , M. M. Jimenez-Carmona, J. L. Ubera, M. D. L. de Castro. J. Chromatogr., A 855, 625 (1999).CrossrefGoogle Scholar

  • 78.

    , A. Basile, M. M. Jimenez-Carmona, A. A. Clifford. J. Agric. Food Chem. 46, 5205 (1998).CrossrefGoogle Scholar

  • 79.

    V. B. Guliyeva, M. Gulb, A. Yildirima. J. Chromatogr., B 812, 291 (2004).Google Scholar

  • 80.

    , K. Hostettmann, J. L. Wolfender. "Rapid determination on plant glycosides by LC/MS and LC/NMR", in Advances in Plant Glycosides, Chemistry and Biology, C. R. Yang, O. E. Tanaka (Eds.), p. 233, Elsevier, Amsterdam (1999).CrossrefGoogle Scholar

  • 81.

    , P. S. Belton, I. J. Colquhoun, E. K. Kemsley, I. Delgadillo, P. Roma, M. J. Dennis, M. Sharman, E. Holmes, J. K. Nicholson, M. Spraul. Food Chem. 61, 207 (1998).CrossrefGoogle Scholar

  • 82.

    , M. Frederich, Y. H. Choi, L. Angenot, G. Harnischfeger, A. W. M. Lefeber, R. Verpoorte. Phytochemistry 65, 1993 (2004).CrossrefGoogle Scholar

  • 83.

    , H. K. Choi, Y. H. Choi, M. Verberne, A. W. M. Lefeber, C. Erkelens, R. Verpoorte. Phytochemistry 65, 857 (2004).CrossrefGoogle Scholar

  • 84.

    P. J. Hylands, J. K. Nicholson, E. Holmes, M. J. Dunn. U.S. patent 6806090 (2004).Google Scholar

  • 85.

    , P. Mionodies, P. Pommier, E. Moulene, K. Retornaz, N. Prost, L. Dehoro. Arch. Pediatrics 10, 619 (2003).CrossrefGoogle Scholar

  • 86.

    Anon. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine, p. 4, World Health Organization, Geneva (2000).Google Scholar

  • 87.

    , A. T. Elamthuruthya, C. R. Shah, T. A. Khan, P. A. Tatke, S. Y. Gabhe. J. Pharm. Biomed Anal. 37, 937 (2005).CrossrefGoogle Scholar

  • 88.

    , G. Biringanine, M.-T. Chirelli, M. Faes, P. Duez. Talanta 69, 418 (2006).CrossrefGoogle Scholar

  • 89.

    , E. A. Abouarshed, I. A. Khan. J. Pharm. Sci. 90, 817 (2001).CrossrefGoogle Scholar

  • 90.

    , H. Elsohly, E. M. Croom, M. A. Elsohly. Pharm. Res. 4, 258 (1987).CrossrefGoogle Scholar

  • 91.

    , H. Ganzora, E. Bedin, I. A. Khan. J. Pharm. Sci. 90, 1752 (2001).CrossrefGoogle Scholar

  • 92.

    M. Ganzora, I. A. Khan. Planta Med. 67, 778 (2001).CrossrefGoogle Scholar

  • 93.

    , R. B. Anna, C. B. Maria, L. Diamanto, F. V. Franco. J. Agric. Food Chem. 50, 5016 (2002).CrossrefGoogle Scholar

  • 94.

    G. M. Hanna. 11th Annual FDA Science Forum, Board Number: I-14, April 27 (2005).Google Scholar

  • 95.

    L. Wang, F. S. C. Lee, X. Wang. LWT-Food Sci. Technol. 40, 83 (2007).Google Scholar

  • 96.

    Romanian Pharmacopoeia X, Chap. IX, Ed, Medicala, Bucuresti (1993).Google Scholar

  • 97.

    British Pharmacopoeia, Vol. IV, Appendix XVI B, A356-A363 (2005).Google Scholar

  • 98.

    , A. Ozbey, U. Uygun. Int. J. Food Sci. Technol. 42, 380 (2007).CrossrefGoogle Scholar

  • 99.

    R. O. B. Wijesekera (Ed.). The Medicinal Plant Industry, CRC Press, Boca Raton (1991).Google Scholar

  • 100.

    , V. Rai, P. Kakkar, C. Misra, S. K. Ojha, N. Srivastava, S. Mehrotra. Environ. Contam. Toxicol. 79, 269 (2007).CrossrefGoogle Scholar

  • 101.

    H. Wagner. In Handbook of Medicinal Plants, Z. Yaniv, U. E. Bachrach (Eds.), p. 3, Chap. 21, Haworth Medical Press, Binghamton (2001).Google Scholar

  • 102.

    , V. G. Zuin, J. H. Yariwake, F. M. Lancas. J. Braz. Chem. Soc. 14, 304 (2003).CrossrefGoogle Scholar

  • 103.

    V. G. Zuin, A L. Lopes, J. H. Yarawake, F. Augusto. J. Chromatogr., A 1056, 21 (2004).Google Scholar

  • 104.

    , S. Razic, A. Onjia, S. Dogo, L. Slavkovic, A. Popovic. Talanta 67, 233 (2005).CrossrefGoogle Scholar

  • 105.

    , S. S. Razic, S. M. Dogo, L. J. Slavkovic. Microchem. J. 84, 93 (2006).CrossrefGoogle Scholar

  • 106.

    , S. Razic, S. Dogo, L. Slavkovic. J. Serb. Chem. Soc. 71, 1095 (2006).CrossrefGoogle Scholar

  • 107.

    , V. M. Dirsch, A. K. Kiemer, H. Wagner, A. M. Vollmar. Atherosclerosis 139, 333 (1998).CrossrefGoogle Scholar

  • 108.

    V. M. Dirsch, A. L. Gerbes, A. M. Vollmar. Mol. Pharmacol. 53, 402 (1998).Google Scholar

  • 109.

    S. Klingelhofer. Isolierung und Charakterisierung antiinflammatorischer Oxylipine aus Blattextrakten von Urtica dioica L., Ph.D. Thesis, Kiel, Germany, Christian-Albrechts-Universitat, pp. 1-3 and 80 (2001).Google Scholar

  • 110.

    , M. Kaszkin, K. F. Beck, E. Koch, C. Erdelmeier, S. Kusch, J. Pfeilschifter, D. Loew. Phytomedicine 11, 585 (2004).CrossrefGoogle Scholar

  • 111.

    W. E Mueller. St. John's Wort and its Active Principles in Depression and Anxiety, Birkhauser, Basel (2005).Google Scholar

  • 112.

    , R. Verpoorte, Y. H. Choi, H. K. Kim. J. Ethnopharmacol. 100, 53 (2005).CrossrefGoogle Scholar

  • 113.

    , E. M. Williamson. Phytomedicine 8, 401 (2001).CrossrefGoogle Scholar

  • 114.

    API (Ayurvedic Pharmacopoeia of India). Department of Health, Ministry of Health and Family Welfare, Government of India, New Delhi, p. 45 (1989).Google Scholar

  • 115.

    P. P. H. But, T. Kimura, J.-X. Guo, C. K. Sung, B. H. Han (Eds.). International Collation of Traditional and Folk Medicine, p. 232, World Scientific, Singapore (1997).Google Scholar

  • 116.

    H. M. Chang, P. P. H. But (Eds.). Pharmacology and Applications of Chinese Materia Medica, Vols. I and II, S.-C. Yao, L.-L. Wang, S. C.-S. Yeung (Translators), World Scientific, Philadelphia (2001).Google Scholar

  • 117.

    V. K. Gupta. Traditional Knowledge Digital Library, Sub-Regional Experts Meeting in Asia on Intangible Cultural Heritage: Safeguarding and Inventory-Making Methodologies, Bangkok (2005). <http://www.accu.or.jp/ich/en/pdf/c2005subreg_ Ind1.pdf>.Google Scholar

  • 118.

    JSHM. Japanese Standards for Herbal Medicines, p. 361, Yakuji Nippo, Tokyo (1993).Google Scholar

  • 119.

    Jiangsu Institute of Modern Medicine. Zhong Yao Da Ci Dian (Encyclopedia of Chinese Materia Medica), Vols. 1-3, p. 3518, Shanghai Scientific and Technical Publications, Shanghai (1977).Google Scholar

  • 120.

    L. D. Kapoor. CRC Handbook of Ayurvedic Medicinal Plants, Herbal Reference Library, p. 416, CRC Press, Boca Raton (2001).Google Scholar

  • 121.

    K. M. Nadkarni. Indian Materia Medica, p. 414, Popular Prakashan, Bombay (1976).Google Scholar

  • 122.

    T. C. Lantz. Examining the Potential Role of Co-operatives in the Ethical Commercialisation of Medicinal Plants, Plant Conservation Intellectual Property Rights, Ethics, and the Devil's Club (Oplopanax Horridus). Occasional Papers 3, BC Institute for Co-operative Studies, University of Victoria, Victoria, B.C., Canada, 27 (2001).Google Scholar

  • 123.

    G. Tu (Ed.). Pharmacopoeia of the People's Republic of China (English ed., 1992), p. 202, Guangdong Science and Technology Press, Beijing (1992).Google Scholar

  • 124.

    United Nations. Convention on Biological Diversity, United Nations Treaty Series UN, New York, Vol. 1760, I-30619, 143 (1993).Google Scholar

  • 125.

    Online Archive of American Folk Medicine, University of California, Los Angeles. <http://www.folkmed.ucla.edu/>.Google Scholar

  • 126.

    Phytotherapies database. <http://www.phytotherapies.org/>.Google Scholar

  • 127.

    Natural Medicines Comprehensive Database. <http://www.naturaldatabase.com/>.Google Scholar

  • 128.

    HerbMed. <http://www.herbmed.org/HerbMed>.Google Scholar

  • 129.

    <http://www.cintcm.com/index.htm>.Google Scholar

  • 130.

    , M. Van Dongen, E. Van Rossum, A. Kessels, H. Sielhorst. P. Knipschild. J. Clin. Epidem. 56, 367 (2003).CrossrefGoogle Scholar

  • 131.

    AGRICOLA database, U.S. Department of Agriculture. <http://agricola.nal.usda.gov>.Google Scholar

  • 132.

    AltHealth Watch database. <http://www.epnet.com>.Google Scholar

  • 133.

    MANTIS database. <http://www.healthindex.com/>.Google Scholar

  • 134.

    MICROMEDEX database. <http://www.micromedex.com/products/altmeddex/>.Google Scholar

  • 135.

    Computer Retrieval of Information on Scientific Projects. <http://crisp.cit.nih.gov/>.Google Scholar

  • 136.

    Cochrane Collaboration. <http://www.cochrane.org/>.Google Scholar

  • 137.

    EMBASE, Elsevier. <http://www.embase.com/>.Google Scholar

  • 138.

    NAPRALERT, College of Pharmacy, University of Illinois at Chicago. <http://napralert.org/>.Google Scholar

  • 139.

    International Bibliographic Information on Dietary Supplements (IBIDS) database. <http://ods.od.nih.gov/Health_Information/IBIDS.aspx>.Google Scholar

  • 140.

    European Scientific Co-operative on Phytotherapy (ESCOP) database. <http://www.escop.com/phytonet.htm>.Google Scholar

  • 141.

    , B. K. Vogler, M. H. Pittler, E. Ernst. Eur. J. Clin. Pharmacol. 55, 567 (1999).CrossrefGoogle Scholar

  • 142.

    S. I. Hakky. U.S. Patent 4826684 (1989). <http://www.freepatentsonline.com/4826684.html>.Google Scholar

  • 143.

    S. Y. Lee. U.S. Patent 6692777 (2004). <http://www.patentstorm.us/patents/6692777.html>.Google Scholar

  • 144.

    R. Glaser. U.S. Patent 20070059384 (2007). <http://www.freepatentsonline.com/20070059384.html>.Google Scholar

  • 145.

    WHO. WHO Monographs of Selected Medicinal Plants, Vol. 1, p. 289, World Health Organization, Geneva, Switzerland (1999).Google Scholar

  • 146.

    WHO. WHO Monographs of Selected Medicinal Plants, Vol. 2, p. 351, World Health Organization, Geneva, Switzerland (2002).Google Scholar

About the article

Published Online: 2009-01-01

Published in Print: 2008-01-01


Citation Information: Pure and Applied Chemistry, ISSN (Online) 1365-3075, ISSN (Print) 0033-4545, DOI: https://doi.org/10.1351/pac200880102195.

Export Citation

© 2013 Walter de Gruyter GmbH, Berlin/Boston. Copyright Clearance Center

Comments (0)

Please log in or register to comment.
Log in